• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 12/6/24: Advantages of New Medicare Rx Payment Plan, Stigma Against Smokers Among Future Healthcare Providers & more

News
Article

The latest news for pharma industry insiders.

The Advantages of New Medicare Rx Payment Plan

While the program could be a good option for many, it's not a panacea.

Study Reveals Stigma Against Smokers Among Future Healthcare Providers

Patients and their caregivers might benefit from being aware of the stigma to advocate for compassionate, optimal care.

Lilly to Boost Weight-Loss Drug Supply With $3 Billion Expansion

Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs.

Aktana Announces First-To-Market GenAI Agents That Survive CRM Transitions

Aktana, Inc., the leader in intelligent customer engagement for the global life sciences industry, today announced the Aktana Action Agent - designed to empower field teams and future-proof omnichannel engagement.

Alvin Massy on LinkedIn

Patients do not want to be defined by their therapies (or as widgets) but as individuals.
Conversation between William Grambley and Miranda Schmalfuhs about using AI to predict and influence patient behavior, adherence and ethical implications

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs